Adam C. Vandervoort - 29 Nov 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF LEGAL OFFICER, SECRETARY
Signature
/s/ Adam C. Vandervoort
Issuer symbol
TDOC
Transactions as of
29 Nov 2024
Net transactions value
-$47,756
Form type
4
Filing time
03 Dec 2024, 17:29:01 UTC
Previous filing
04 Sep 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1,505 +3.3% 47,755 29 Nov 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1,881 +3.9% 49,636 29 Nov 2024 Direct F2
transaction TDOC Common Stock Options Exercise +4,418 +8.9% 54,054 29 Nov 2024 Direct F2
transaction TDOC Common Stock Sale $47,756 -4,004 -7.4% $11.93 50,050 02 Dec 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -1,505 -17% $0.000000 7,530 29 Nov 2024 Common Stock 1,505 Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -1,881 -50% $0.000000 1,881 29 Nov 2024 Common Stock 1,881 Direct F2, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -4,418 -17% $0.000000 22,090 29 Nov 2024 Common Stock 4,418 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.